Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin
Authors:
- 1 February 1988
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 21 (1) , 85-86
Abstract
Summary A positive direct antiglobulin test (DAT) and hemolitic anemia are uncommon side effect of cisplatin (CDDP) therapy. A 9-year-old girl treated for extraosseus Ewing's sarcoma with a multiagent regimen, including 200 mg/m2 CDDP preceded by vincristine (VCR) and cyclophosphamide (CY), developed a posititve DAT, followed by hemolitic anemia. When CDDP therapy was discontinued, the DAT became negative and no signs of anemia were observed during the maintenance treatment, which included VCR and actinomycin D.Keywords
This publication has 7 references indexed in Scilit:
- Resistant and relapsing neuroblastoma: Improved response rate with a new multiagent regimen (OC‐HDP) including high‐dose cisplatinumMedical and Pediatric Oncology, 1987
- HEMOLYTIC-ANEMIA ASSOCIATED WITH ANTINEOPLASTIC AGENTS1985
- Cisplatin-induced anemia.1981
- Haemolytic anaemia after cisplatin treatment.BMJ, 1981
- Cisplatin-Induced HemolysisNew England Journal of Medicine, 1980
- Cis-platinum: a new anticancer agent.BMJ, 1979
- Antibody elution from red blood cellsJournal of Clinical Pathology, 1963